Yigal Nochomovitz's Stock Ratings

Citigroup Analyst

Yigal Nochomovitz is an analyst at Citigroup. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/17/2024

Overall Average Return

5.86%

Smart Score

61.2%

Overall Average Return Percentile

49th

Number of Ratings

169
Buy NowGet Alert
05/09/2024SNDXBuy Now
Syndax Pharmaceuticals
$20.2947.86%$32 → $30MaintainsBuyGet Alert
05/08/2024APLSBuy Now
Apellis Pharmaceuticals
$41.2845.35%$67 → $60MaintainsBuyGet Alert
05/07/2024OVIDBuy Now
Ovid Therapeutics
$3.1511.11%$4 → $3.5MaintainsNeutralGet Alert
05/07/2024ORICBuy Now
ORIC Pharmaceuticals
$9.1652.84%$15 → $14MaintainsBuyGet Alert
05/07/2024SMMTBuy Now
Summit Therapeutics
$4.4059.03% → $7Initiates → BuyGet Alert
05/03/2024ZYMEBuy Now
Zymeworks
$9.1275.44%$17 → $16MaintainsBuyGet Alert
05/03/2024ARDXBuy Now
Ardelyx
$7.9176.99%$13 → $14MaintainsBuyGet Alert
04/18/2024CRSPBuy Now
CRISPR Therapeutics
$55.9059.21%$88 → $89MaintainsBuyGet Alert
04/18/2024PRQRBuy Now
ProQR Therapeutics
$1.943.09%$1.8 → $2MaintainsNeutralGet Alert
04/10/2024LENZBuy Now
LENZ Therapeutics
$16.35107.95% → $34Initiates → BuyGet Alert
03/21/2024IDYABuy Now
IDEAYA Biosciences
$40.5048.15%$40 → $60MaintainsBuyGet Alert
03/11/2024MGNXBuy Now
Macrogenics
$4.50455.56%$13 → $25MaintainsBuyGet Alert
03/07/2024RIGLBuy Now
Rigel Pharmaceuticals
$0.98309.37%$3 → $4MaintainsBuyGet Alert
02/29/2024ZLABBuy Now
Zai Lab
$19.50238.46%$123 → $66MaintainsBuyGet Alert
02/27/2024KRYSBuy Now
Krystal Biotech
$164.1018.83%$160 → $195MaintainsBuyGet Alert
02/26/2024HARPBuy Now
Harpoon Therapeutics
$13 → $23DowngradeBuy → NeutralGet Alert
02/20/2024AVBPBuy Now
ArriVent BioPharma
$20.1049.25% → $30Initiates → BuyGet Alert
02/16/2024APLTBuy Now
Applied Therapeutics
$4.5852.67%$5 → $7MaintainsBuyGet Alert
02/15/2024ARVNBuy Now
Arvinas
$32.6868.3%$36 → $55DowngradeBuy → NeutralGet Alert
02/14/2024ARVNBuy Now
Arvinas
$32.6868.3%$36 → $55DowngradeBuy → NeutralGet Alert
02/08/2024ARCTBuy Now
Arcturus Therapeutics
$29.7861.18%$40 → $48MaintainsBuyGet Alert
01/30/2024OLMABuy Now
Olema Pharmaceuticals
$9.84103.25% → $20Initiates → BuyGet Alert
01/10/2024ARDXBuy Now
Ardelyx
$7.9176.99%$9 → $14MaintainsBuyGet Alert
12/20/2023MRTXBuy Now
Mirati Therapeutics
$48 → $59DowngradeBuy → NeutralGet Alert
12/20/2023MGNXBuy Now
Macrogenics
$4.50188.89%$7 → $13UpgradeNeutral → BuyGet Alert
12/15/2023APLSBuy Now
Apellis Pharmaceuticals
$41.2862.31%$70 → $67MaintainsBuyGet Alert
12/08/2023BMEABuy Now
Biomea Fusion
$12.24635.29% → $90ReiteratesBuy → BuyGet Alert
10/26/2023ZLABBuy Now
Zai Lab
$19.50556.41%$130 → $128MaintainsBuyGet Alert
10/26/2023BGNEBuy Now
BeiGene
$172.8564.88%$290 → $285MaintainsBuyGet Alert
10/24/2023ARVNBuy Now
Arvinas
$32.6810.16%$72 → $36MaintainsBuyGet Alert